Author: Banno H. Kawazura H. Yutaka T. Sakuma N. Kitamori T. Hosoya J. Kibayashi K. Yamashita H. Umemura K. Nakashima M.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.367, Iss.2, 1999-02, pp. : 275-282
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anti-aggregatory drugs: I. Platelet receptor antagonists
By Geiger J.
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. :
Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist
By Moritani Y. Sato K. Shigenaga T. Hisamichi N. Ichihara M. Akamatsu S. Suzuki K.-i. Nii T. Kaku S. Kawasaki T. Matsumoto Y. Inagaki O. Tomioka K. Yanagisawa I.
European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. :
Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential
Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. :